Masayuki Ninomiya Selected Research

Masayuki Ninomiya Research Topics

Disease

8	Leukemia 10/2017 - 08/2009
7	Neoplasms (Cancer) 11/2020 - 01/2011
2	T-Cell Leukemia (Leukemia, T Cell) 05/2018 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 07/2012
1	Non-alcoholic Fatty Liver Disease 07/2021
1	Skin Neoplasms (Skin Cancer) 11/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Adenocarcinoma of Lung 05/2018
1	Necrosis 05/2018
1	Atherosclerosis 11/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Microphthalmos 10/2015
1	Melanoma (Melanoma, Malignant) 10/2015
1	Inflammation (Inflammations) 06/2014
1	Neuroinflammatory Diseases 01/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2013
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Fibrosis (Cirrhosis) 07/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2012
1	Liver Diseases (Liver Disease) 07/2012
1	Central Nervous System Diseases (CNS Diseases) 09/2011
1	Experimental Melanoma 10/2010
1	Type 2 Diabetes Mellitus (MODY) 06/2010

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 09/2016 - 08/2010
2	Pharmaceutical PreparationsIBA 07/2021 - 11/2020
2	QuinoxalinesIBA 11/2020 - 11/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2016 - 10/2013
2	FlavonoidsIBA 01/2016 - 08/2009
1	PhytochemicalsIBA 07/2021
1	XK 469 (XK469)IBA 11/2020
1	EAPB0203IBA 11/2020
1	ThiadiazolesIBA 11/2020
1	Imiquimod (Aldara)FDA LinkGeneric 11/2020
1	AminesIBA 11/2020
1	OxadiazolesIBA 11/2020
1	pterostilbeneIBA 01/2019
1	pallidolIBA 01/2019
1	boehmenanIBA 01/2019
1	PhytolIBA 05/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2018
1	CoumarinsIBA 01/2018
1	tert-ButylhydroperoxideIBA 01/2018
1	EstersIBA 10/2017
1	LuteolinIBA 11/2016
1	oxidized low density lipoproteinIBA 11/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2016
1	echinochrome AIBA 09/2016
1	Methanol (Carbinol)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	Histones (Histone)IBA 01/2016
1	IsoenzymesIBA 01/2016
1	Superoxide DismutaseIBA 01/2016
1	Butyric Acid (Butanoic Acid)IBA 01/2016
1	Melanocyte-Stimulating Hormones (MSH)IBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	Carrier Proteins (Binding Protein)IBA 10/2015
1	dioscinIBA 10/2015
1	ElementsIBA 10/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2015
1	NaphthoquinonesIBA 08/2015
1	CytokinesIBA 06/2014
1	endonuclease GIBA 01/2014
1	Chalcone (Benzalacetophenone)IBA 01/2014
1	E-SelectinIBA 08/2013
1	polyalthialdoic acidIBA 01/2013
1	Clerodane DiterpenesIBA 01/2013
1	kolavenic acidIBA 01/2013
1	flavoneIBA 07/2012
1	Biological ProductsIBA 07/2012
1	tricinIBA 07/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2011
1	GlycosaminoglycansIBA 01/2011
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2011
1	xylosidesIBA 01/2011
1	matrigelIBA 01/2011
1	O-methylmoschatolineIBA 10/2010
1	Melanins (Melanin)IBA 10/2010
1	cinnamic acidIBA 08/2010
1	1-O-trans-cinnamoyl-beta-D-glucopyranoseIBA 08/2010
1	Acarbose FDA LinkGeneric 06/2010
1	Glycoside Hydrolase InhibitorsIBA 06/2010
1	Advanced Glycation End ProductsIBA 06/2010
1	GlyceraldehydeIBA 06/2010
1	Immunoglobulin E (IgE)IBA 08/2009

Therapy/Procedure

1	Therapeutics 11/2020
1	Chemoprevention 10/2017